We also noted reduced frequencies of CD86+ naïve (ID110) and memory B-cell populations (ID98) (Additional file 3: Figure S3) and several activated memory B-cell subsets with significantly different variances between AML and HD (summarized in Additional file 2: Table S4). This evidence concerns the gene CD86 and Huntington disease.